Home  Feedback  Career  Sitemap  Contact Us
 
Market Buzz
Corporate Info
Market Analysis
Movers
Corporate Action
Other Markets
IPO
 
Sun Pharmaceuticals Industries Ltd
  Sun Pharma partners with The National Institute of Virology, Pune | [27-Jun-2017]
  Sun Pharmaceutical Industries Limited - Press Release | [27-Jun-2017]
  Sun Pharmaceutical Industries Limited - Court Convened Meeting Updates | [22-Jun-2017]
  Sun Pharmaceutical Industries Limited - Court Convened Meeting Updates | [21-Jun-2017]
  Other announcement of Sun Pharmaceutical Industrie | [14-Jun-2017]
  Sun Pharmaceutical Industries receives final approval for generic ezetimibe tablets | [13-Jun-2017]
  Sun Pharma rises after USFDA approval for generic drug | [13-Jun-2017]
  Board of Sun Pharmaceuticals Industries recommends final dividend | [13-Jun-2017]
  Sun Pharmaceutical Industries Limited - Press Release | [13-Jun-2017]
  Sun Pharmaceutical Industries Limited - Updates | [31-May-2017]
  Sun Pharma tanks after posting dismal Q4 results | [29-May-2017]
  Other announcement of Sun Pharmaceutical Industrie | [29-May-2017]
  Sun Pharmaceutical Industries Limited - Dividend | [29-May-2017]
  Sun Pharmaceuticals Industries standalone net profit rises 84.32% in the March 2017 quarter | [27-May-2017]
  Sun Pharmaceuticals Industries consolidated net profit declines 16.67% in the March 2017 quarter | [27-May-2017]
Back Top
Source:Capital Market

Member Code : NCDEX - 00241 | MCX - 31435
SEBI Regn. Nos : BSE INB010643030 | NSE(EQ) INB230643037 | NSE(FUT) INF230643037 FOR INVESTORS GRIEVANCE : complaints@cilsecurities.com
FOR DP GRIEVANCE : grievance@cilsecurities.com
Privacy Policy  |  Disclaimer | BrokerNorms |  BSE Complaints
Useful Links :  NSE | BSE  | CDSL | MCX  | NCDEX | SEBI | RBI
Designed , Developed & Powered By C-MOTS Infotech
(ISO 9001:2015 certified)